NIHON CHOUZAI Co.,Ltd.

Yield per half year: +25 442.78%
Dividend yield: 1.87%
Sector: Healthcare

NIHON CHOUZAI Co.,Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
1/10
21488.14 149.2 14301.84% 4308.06 +398.79%
P/S 82.91 86.18 -3.8%
P/BV 505.78 74.47 579.13%
P/FCF 12209.97 47.64 25531.57%
Ev/Ebitda 5.81 101.64 -94.28%
Ev/S 0.209 84.24 -99.75%
Ev/FCF 30.78 -66.76 -146.1%
E/P 4.7E-5 0.0262 -99.82%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
1/10
3.6 -190.28 -101.89% 4.39 -18%
ROE 2.35 -9.77 -124.1%
ROA 0.7057 0.7046 0.1644%
ROIC 2.92 8 -63.57%
ROS 0.3858 -225.69 -100.17%
ROCE 5.58 -7.48 -174.64%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
2/10
4.49 6.69 -32.8% 3.98 +12.91%
Nеt Debt/Ebitda 2.38 -56.44 -104.21%
Debt/Ratio 0.2956 0.1494 97.89%
Debt/Equity 2.34 1.1 112.81%
Debt/Net Income 41.89 6.07 589.79%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
4.68/10
1.87 1.79 4.18% 1.96 -4.75%
Number of years of dividend growth 0 1.76 -100%
DSI 0.8571 0.717 19.54%
Average dividend growth -12.5 -106.57 -88.27%
Average percentage for 5 years 1.96 17.41 -88.72%
Average percentage for payments 23.31 43.79 -46.76%
Difference from average difference in sector 0.075

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
4/10
29.24 206.62 -85.85%
Growth impulse Ebitda in 5 years -24.31 378.35 -106.43%
Growth impulse Net Income in 5 years -60.71 262.82 -123.1%
Growth impulse FCF in 5 years -47.8 291.18 -116.42%
Growth impulse EPS in 5 years -60.56 121.69 -149.77%
IP Score
2.91/10

Similar companies

Sumitomo Pharma Co., Ltd.

Sosei Group Corporation

Taisho Pharmaceutical Holdings Co., Ltd.

Kusuri No Aoki Holdings Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription